Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.3K
Overview
45.3K
Development of Immunocompetence01:22

Development of Immunocompetence

444
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
444
Immunological Memory01:23

Immunological Memory

4.7K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
4.7K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

311
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
311
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

665
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
665
Cross-reactivity00:42

Cross-reactivity

31.5K
Overview
31.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subverting Host Defense from Within: Innate Immune Modulation by <i>Coxiella burnetii</i>.

Pathogens (Basel, Switzerland)·2026
Same author

CYP1B1-AS1 regulates CYP1B1 to promote Coxiella burnetii pathogenesis by inhibiting ROS and host cell death.

Nature communications·2025
Same author

Microfluidic droplets with amended culture media cultivate a greater diversity of soil microorganisms.

Applied and environmental microbiology·2025
Same author

CYP1B1-AS1 regulates CYP1B1 to promote <i>Coxiella burnetii</i> pathogenesis by inhibiting ROS and host cell death.

Research square·2024
Same author

Multivalent vaccines demonstrate immunogenicity and protect against <i>Coxiella burnetii</i> aerosol challenge.

Frontiers in immunology·2023
Same author

The emerging roles of long non-coding RNA in host immune response and intracellular bacterial infections.

Frontiers in cellular and infection microbiology·2023

Related Experiment Video

Updated: Sep 8, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.8K

Immunogenicity and Reactogenicity in Q Fever Vaccine Development.

Alycia P Fratzke1,2, Erin J van Schaik2, James E Samuel1,2

  • 1Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, United States.

Frontiers in Immunology
|June 13, 2022
PubMed
Summary

Preventing Q fever requires effective vaccines against Coxiella burnetii. Current vaccines cause severe reactions, hindering use. Future strategies aim to improve vaccine safety and efficacy for better Coxiella burnetii prevention.

Keywords:
Coxiella burnetiiQ feverhypersensitivityimmunogenicityreactogenicityvaccine

More Related Videos

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.8K
The Development of Lyophilized Loop-mediated Isothermal Amplification Reagents for the Detection of Coxiella burnetii
07:27

The Development of Lyophilized Loop-mediated Isothermal Amplification Reagents for the Detection of Coxiella burnetii

Published on: April 18, 2016

10.6K

Related Experiment Videos

Last Updated: Sep 8, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.8K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.8K
The Development of Lyophilized Loop-mediated Isothermal Amplification Reagents for the Detection of Coxiella burnetii
07:27

The Development of Lyophilized Loop-mediated Isothermal Amplification Reagents for the Detection of Coxiella burnetii

Published on: April 18, 2016

10.6K

Area of Science:

  • Microbiology
  • Immunology
  • Vaccinology

Background:

  • Coxiella burnetii causes Q fever, a potentially severe disease affecting humans worldwide.
  • Transmission occurs via aerosols, with domestic livestock acting as reservoirs, making elimination difficult.
  • Current prevention relies on vaccination, but the only licensed human vaccine has significant reactogenicity issues.

Purpose of the Study:

  • To review current and past research on Coxiella burnetii vaccines.
  • To assess the immunogenicity and reactogenicity of existing vaccines.
  • To explore future strategies for developing safer and more effective vaccines.

Main Methods:

  • Comprehensive literature review of Coxiella burnetii vaccine research.
  • Analysis of immunogenicity and reactogenicity data from vaccine studies.
  • Exploration of novel vaccine development approaches and safety considerations.

Main Results:

  • Limited vaccine options exist, with the current formalin-inactivated whole cell vaccine showing reactogenicity concerns.
  • Understanding of Coxiella burnetii pathogenesis and vaccine-induced immune responses is incomplete.
  • Significant challenges remain in developing vaccines that are both immunogenic and well-tolerated.

Conclusions:

  • Improved Coxiella burnetii vaccine safety is crucial for widespread prevention of Q fever.
  • Further research into vaccine immunogenicity and reactogenicity is needed.
  • Novel vaccine strategies are required to overcome the limitations of current approaches.